Pneumonia Research Today is a free monthly online journal that collates and summarizes the latest research about Pneumonia, including details on symptoms, viral, bacterial, treatment, causes, walking pneumonia.

Volume 2 (2005), Issue 4 (April)

1. Nonresolving pneumonia.
   Clin Chest Med, 26(1): 143-58. [Abstract] [Full-text]
2. Prevention of pneumonia in the hospital setting.
   Clin Chest Med, 26(1): 135-42. [Abstract] [Full-text]
3. Preventing pneumonia: the role for pneumococcal and influenza vaccines.
   Clin Chest Med, 26(1): 123-34. [Abstract] [Full-text]
4. Pneumonia in the solid organ transplant patient.
   Clin Chest Med, 26(1): 113-21. [Abstract] [Full-text]
5. Acute lung injury and bacterial infection.
   Clin Chest Med, 26(1): 105-12. [Abstract] [Full-text]
6. Antimicrobial treatment of hospital-acquired pneumonia.
   Clin Chest Med, 26(1): 97-104. [Abstract] [Full-text]
7. Etiology of ventilator-associated pneumonia.
   Clin Chest Med, 26(1): 87-95. [Abstract] [Full-text]
8. Microbiologic diagnosis of ventilator-associated pneumonia.
   Clin Chest Med, 26(1): 81-6. [Abstract] [Full-text]
9. Mechanisms of resistance of bacteria causing ventilator-associated pneumonia.
   Clin Chest Med, 26(1): 75-9. [Abstract] [Full-text]
10. Antimicrobial treatment of community-acquired pneumonia.
    Clin Chest Med, 26(1): 65-73. [Abstract] [Full-text]
11. Antimicrobial resistance and treatment of community-acquired pneumonia.
    Clin Chest Med, 26(1): 57-64. [Abstract] [Full-text]
12. Etiology of community-acquired pneumonia.
    Clin Chest Med, 26(1): 47-55. [Abstract] [Full-text]
13. Pathophysiology of pneumonia.
    Clin Chest Med, 26(1): 39-46. [Abstract] [Full-text]
14. Genetic susceptibility to pneumonia.
    Clin Chest Med, 26(1): 29-38. [Abstract] [Full-text]
15. Community-acquired pneumonia and sepsis.
    Clin Chest Med, 26(1): 19-28. [Abstract] [Full-text]
16. Pulmonary host defenses and factors predisposing to lung infection.
    Clin Chest Med, 26(1): 11-7. [Abstract] [Full-text]
17. The systemic response to lung infection.
    Clin Chest Med, 26(1): 1-9. [Abstract] [Full-text]
18. An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care.
    Curr Med Res Opin, 21(2): 261-70. [Abstract] [Full-text]
19. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia.
    Am J Med, 118(4): 384-92. [Abstract] [Full-text]
20. Community-acquired pneumonia as the initial manifestation of serious underlying diseases.
    Am J Med, 118(4): 378-83. [Abstract] [Full-text]
21. Can clinical signs predict hypoxaemia in Papua New Guinean children with moderate and severe pneumonia?
    Ann Trop Paediatr, 25(1): 23-7. [Abstract] [Full-text]
22. Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone.
    Eur J Clin Microbiol Infect Dis, 24(3): 190-5. [Abstract] [Full-text]
23. Community-acquired adenovirus pneumonia in a patient with chronic lymphatic leukaemia.
    Eur J Clin Microbiol Infect Dis, 24(3): 217-9. [Abstract] [Full-text]
24. Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients.
    Chest, 127(4): 1276-82. [Abstract] [Full-text]
25. Intrathoracic lymphadenopathy in hospitalized patients with pneumococcal pneumonia.
    Chest, 127(4): 1271-5. [Abstract] [Full-text]
26. Factors influencing in-hospital mortality in community-acquired pneumonia: a prospective study of patients not initially admitted to the ICU.
    Chest, 127(4): 1260-70. [Abstract] [Full-text]
27. Effect of nicotine on lung S-adenosylmethionine and development of Pneumocystis pneumonia.
    J Biol Chem, 280(15): 15219-28. [Abstract] [Full-text]
28. Inflammation--a new therapeutic target in pneumonia.
    Respiration, 72(2): 117-26. [Abstract] [Full-text]
29. DNA identification of the pathogen of candidal aspiration pneumonia induced in the course of oral cancer therapy.
    J Med Microbiol, 54: 493-6. [Abstract] [Full-text]
30. Patterns of health care resource utilization after macrolide treatment failure: results from a large, population-based cohort with acute sinusitis, acute bronchitis, and community-acquired pneumonia.
    Clin Ther, 26(12): 2153-62. [Abstract] [Full-text]
31. Bronchoscopic intralesional injection of triamcinolone acetonide treated against bronchial obstruction caused by peanut aspiration.
    Respir Med, 99(5): 645-7. [Abstract] [Full-text]
32. Ventilator-associated pulmonary infection: the germ theory of disease remains viable.
    Microbes Infect, 7(2): 279-91. [Abstract] [Full-text]
33. Respiratory nosocomial infections in the medical intensive care unit.
    Microbes Infect, 7(2): 292-301. [Abstract] [Full-text]
34. Prevention of hospital infection.
    Microbes Infect, 7(2): 268-74. [Abstract] [Full-text]
35. Impaired recognition by Toll-like receptor 4 is responsible for exacerbated murine Pneumocystis pneumonia.
    Microbes Infect, 7(2): 195-203. [Abstract] [Full-text]
36. Diagnosis of ventilator-associated pneumonia.
    Microbes Infect, 7(2): 262-7. [Abstract] [Full-text]
37. Pneumonia in patients who require prolonged mechanical ventilation.
    Microbes Infect, 7(2): 275-8. [Abstract] [Full-text]
38. Comorbidity in childhood in northern Ghana: magnitude, associated factors, and impact on mortality.
    Int J Epidemiol, 34(2): 368-75. [Abstract] [Full-text]
39. Pulmonary and extrapulmonary acute lung injury: inflammatory and ultrastructural analyses.
    J Appl Physiol, 98(5): 1777-83. [Abstract] [Full-text]
40. CD11b limits bacterial outgrowth and dissemination during murine pneumococcal pneumonia.
    J Infect Dis, 191(10): 1755-60. [Abstract] [Full-text]
41. An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.
    Int J Infect Dis, 9(3): 144-53. [Abstract] [Full-text]
42. Gianotti-Crosti syndrome in an adult following recent Mycoplasma pneumoniae infection.
    Australas J Dermatol, 46(2): 106-9. [Abstract] [Full-text]
43. Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
44. Neonatal pneumonia in developing countries.
    Arch Dis Child Fetal Neonatal Ed, 90(3): F211-9. [Abstract] [Full-text]
45. Synergistic action of E. coli endotoxin and Pasteurella multocida type A for the induction of bronchopneumonia in pigs.
    Vet J, 169(3): 417-26. [Abstract] [Full-text]
46. Thrombopoietin and interleukin-6 in children with pneumonia-associated thrombocytosis.
    Arch Med Res, 36(2): 124-8. [Abstract] [Full-text]
47. Radiology of community-acquired pneumonia.
    Radiol Clin North Am, 43(3): 497-512, viii. [Abstract] [Full-text]
48. Oxidative stress precedes peak systemic inflammatory response in pediatric patients undergoing cardiopulmonary bypass operation.
    Free Radic Biol Med, 38(10): 1323-32. [Abstract] [Full-text]
49. Computer-assisted decision support for the diagnosis and treatment of infectious diseases in intensive care units.
    Lancet Infect Dis, 5(5): 305-12. [Abstract] [Full-text]
50. Increased circulating endothelial progenitor cells in patients with bacterial pneumonia: evidence that bone marrow derived cells contribute to lung repair.
    Thorax, 60(5): 410-3. [Abstract] [Full-text]
51. Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease.
    Thorax, 60(5): 376-82. [Abstract] [Full-text]

© 2004-2008 Pneumonia Research Today. All Rights Reserved.